We’re excited to share a case study on our successful collaboration with Glatt, highlighting how our FR-JET® technology enables superior liposomal formulation.
Key insights from our feasibility study:
- Successfully formulated naproxen-loaded liposomes using various lipid compositions, highlighting new drug delivery possibilities.
- Achieved liposome sizes ≤150 nm and a PDI of ≤0.14, demonstrating robust and efficient formulation screening.
- Showcased FR-JET® technology’s potential to streamline liposomal research, and optimize scale-up manufacturing for future applications.